Besides DNA methylation levels, many array-based bioinformatics tools have been developed, such as MGMT-STP2713, InfiniumPurify25 (which estimates tumor purity), and ChAMP-CNV26, that allow for further unification of glioma biomarkers into a single assay. The gene discussed is MGMT; the disease is central nervous system cancer.